1. |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024, 74(3): 229-263.
|
2. |
Xi Y, Xu P. Global colorectal cancer burden in 2020 and projections to 2040. Translational oncology, 2021, 14(10): 101174. doi: 10.1016/j.tranon.2021.101174.
|
3. |
Laufman H, Saphir O. Primary linitis plastica type of carcinoma of the colon. AMA Arch Surg, 1951, 62(1): 79-91.
|
4. |
Weng MT, Chao KH, Tung CC, et al. Characteristics of primary signet-ring cell carcinoma of colon and rectum: a case control study. BMC Gastroenterol, 2022, 22(1): 173. doi: 10.1186/s12876-022-02258-1.
|
5. |
Liu Y, Yin W, Li X, et al. Comparative analysis of tumor biology and prognosis in mucinous and signet-ring cell colon cancers versus classical adenocarcinoma. Front Physiol, 2023, 14: 1199211. doi: 10.3389/fphys.2023.1199211.
|
6. |
Li F, Liu L, Feng Q, et al. Prognostic and predictive value of tumor deposits in advanced signet-ring cell colorectal cancer: SEER database analysis and multicenter validation. World J Surg Oncol, 2024, 22(1): 107. doi: 10.1186/s12957-024-03362-0.
|
7. |
Allart M, Leroy F, Kim S, et al. Metastatic colorectal carcinoma with signet-ring cells: Clinical, histological and molecular description from an Association des Gastro-Entérologues Oncologues (AGEO) French multicenter retrospective cohort. Dig Liver Dis., 2022, 54(3): 391-399.
|
8. |
Schulz HH, Dijkstra M, van der Lei S, et al. Local treatment of colorectal liver metastases in the presence of extrahepatic disease: survival outcomes from the amsterdam colorectal liver met registry (AmCORE). Cancers, 2024, 16(6): 1098.
|
9. |
Yan J, Xue X, Gao C, et al. Predicting the Ki-67 proliferation index in pulmonary adenocarcinoma patients presenting with subsolid nodules: construction of a nomogram based on CT images. Quant Imaging Med Surg, 2022, 12(1): 642-652.
|
10. |
Liu H, Li Z, Zhang Q, et al. Multi-institutional development and validation of a nomogram to predict prognosis of early-onset gastric cancer patients. Front Immunol, 2022, 13: 1007176. doi: 10.3389/fimmu.2022.1007176.
|
11. |
He Y, Luo L, Shan R, et al. Development and validation of a nomogram for predicting postoperative early relapse and survival in hepatocellular carcinoma. J Natl Compr Canc Netw, 2023, 22(1D): e237069. doi: 10.6004/jnccn.2023.7069.
|
12. |
毛益虎, 黄理宾, 杨烈. 基于SEER数据库的Ⅳ期结直肠癌早期死亡危险因素分析和预测模型构建及验证. 中国普外基础与临床杂志, 2024, 31(5): 555-564.
|
13. |
Jiang Y, Hu H, Shao X, et al. A novel web-based dynamic prognostic nomogram for gastric signet ring cell carcinoma: a multicenter population-based study. Front Immunol, 2024, 15: 1365834. doi: 10.3389/fimmu.2024.1365834.
|
14. |
Diao JD, Ma LX, Wu CJ, et al. Construction and validation a nomogram to predict overall survival for colorectal signet ring cell carcinoma. Sci Rep, 2021, 11(1): 3382. doi: 10.1038/s41598-021-82978-8.
|
15. |
Yang LL, Wang M, He P. Clinicopathological characteristics and survival in colorectal signet ring cell carcinoma: a population-based study. Sci Rep, 2020, 10(1): 10460. doi: 10.1038/s41598-020-67388-6.
|
16. |
Shen C, Tannenbaum D, Horn R, et al. Overall survival in phase 3 clinical trials and the surveillance, epidemiology, and end results database in patients with metastatic colorectal cancer, 1986-2016: A systematic review. JAMA Netw Open, 2022, 5(5): e2213588. doi: 10.1001/jamanetworkopen.2022.13588.
|
17. |
Wang L, Hirano Y, Heng G, et al. Does signet-ring cell carcinoma component signify worse outcomes for patients with colorectal cancer? Asian J Surg, 2021, 44(1): 105-110.
|
18. |
Nuytens F, Drubay V, Eveno C, et al. Systematic review of risk factors, prognosis, and management of colorectal signet-ring cell carcinoma. World J Gastrointest Oncol, 2024, 16(5): 2141-2158.
|
19. |
Tamhankar AS, Ingle P, Engineer R, et al. Signet-ring colorectal carcinoma: Do we need to improve the treatment algorithm? World J Gastrointest Oncol, 2016, 8(12): 819-825.
|
20. |
Qian S, Villarejo-Campos P, Guijo I, et al. Update for advance CAR-T therapy in solid tumors, clinical application in peritoneal carcinomatosis from colorectal cancer and future prospects. Front Immunol, 2022, 13: 841425. doi: 10.3389/fimmu.2022.841425.
|
21. |
Sugarbaker PH, Chang D. Anatomic sites of disease in colorectal cancer patients recorded at the time of cytoreductive surgery for peritoneal metastases. Eur J Surg Oncol, 2022, 48(5): 946-955.
|
22. |
Tanaka Y, Chino O, Kajiwara H, et al. A rare case of esophageal metastasis from signet-ring cell carcinoma of the cecum. Surg Case Rep, 2023, 9(1): 186. doi: 10.1186/s40792-023-01768-8.
|
23. |
Han Y, Yang W, Ma Q, et al. Case report: Systemic treatment for breast and vulvar metastases from resected rectal signet-ring cell carcinoma. Front Oncol, 2023, 13: 1213888. doi: 10.3389/fonc.2023.1213888.
|
24. |
Park JJ, Snow ZA, Lurz KL, et al. A rare case of signet-ring cell carcinoma of the colon with selective metastasis to the prostate. Urology, 2020, 143: e17-e19. doi: 10.1016/j.urology.2020.05.036.
|
25. |
Bacorn C, Lin LK. Rare signet-ring cell adenocarcinoma of the colon metastasis to the orbit. Case Rep Ophthalmol Med, 2020, 2020(1): 2940579. doi: 10.1155/2020/2940579.
|
26. |
Chrysanthos NV, Nezi V, Zafiropoulou R, et al. Metastatic signet-ring cell carcinoma of the skin. Am J Gastroenterol, 2018, 113(10): 1427. doi: 10.1038/s41395-018-0099-3.
|
27. |
Morales-Cruz M, Salgado-Nesme N, Trolle-Silva AM, et al. Signet-ring cell carcinoma of the rectum: atypical metastatic presentation. BMJ Case Rep, 2019, 12(4): e229135. doi: 10.1136/bcr-2018-229135.
|
28. |
Oh HH, Park YL, Park SY, et al. A disintegrin and metalloprotease 12 contributes to colorectal cancer metastasis by regulating epithelial-mesenchymal transition. Int J Oncol, 2023, 62(4): 50. doi: 10.3892/ijo.2023.5498.
|
29. |
Wang R, Ma X, Li Y, et al. The characteristics and prognostic effect of E-cadherin expression in colorectal signet-ring cell carcinoma. PLoS One, 2016, 11(8): e0160527. doi: 10.1371/journal.pone.0160527.
|
30. |
Wang J, Zhanghuang C, Tan X, et al. Development and validation of a nomogram to predict distant metastasis in elderly patients with renal cell carcinoma. Front Public Health, 2022, 9: 831940. doi: 10.3389/fpubh.2021.831940.
|
31. |
Cervantes A, Adam R, Roselló S, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol, 2023, 34(1): 10-32.
|
32. |
Benesch MGK, Mathieson A. Epidemiology of signet-ring cell adenocarcinomas. Cancers (Basel), 2020, 12(6): 1544. doi: 10.3390/cancers12061544. doi: 10.3390/cancers12061544.
|
33. |
Hugen N, Verhoeven RH, Lemmens VE, et al. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor. Int J Cancer, 2015, 136(2): 333-339.
|
34. |
Shi T, Huang M, Han D, et al. Chemotherapy is associated with increased survival from colorectal signet-ring cell carcinoma with distant metastasis: A surveillance, epidemiology, and end results database analysis. Cancer Med, 2019, 8(4): 1930-1940.
|
35. |
Shi W, Chen J, Yao N, et al. The prognostic ability of radiotherapy of different colorectal cancer histological subtypes and tumor sites. Sci Rep, 2023, 13(1): 11758. doi: 10.1038/s41598-023-38853-9.
|
36. |
Enblad M, Egerszegi PP, Birgisson H, et al. Signet-ring cell colorectal and appendiceal cancer: a small signet-ring cell component is also associated with poor outcome. Cancers (Basel), 2023, 15(9): 2497. doi: 10.3390/cancers15092497.
|
37. |
Nie D, Zheng H, An G, et al. Development and validation of a novel nomogram for postoperative overall survival of patients with primary gastric signet-ring cell carcinoma: a population study based on SEER database. J Cancer Res Clin Oncol, 2023, 149(11): 8593-8603.
|
38. |
Zhou D, Yang YJ, Han L, et al. A nomogram for the prediction of survival for colorectal signet-ring cell carcinoma after surgery: A population-based study. Medicine (Baltimore), 2023, 102(48): e36453. doi: 10.1097/MD.0000000000036453.
|